Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation

Journal of Asthma

Volumn 42, Issue 5, 2005, Pages 331-336

  De Benedictis, Fernando Maria ^a,g   Del Giudice, Michele Miraglia ^b   Vetrella, Mario ^c   Tressanti, Flaviana ^d   Tronci, Alessandro ^e   Testi, Renato ^f   Dasic, Gorana ^f  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Ospedale S Maria delle Grazie   (Italy)

^d S G MOSCATI HOSPITAL   (Italy)

^e Ospedale Tamburine   (Italy)

^f GSK   (Italy)

^g Ospedale Pediatrico G Salesi   (Italy)

Author keywords

Budesonide; Childhood asthma; Fluticasone propionate

Indexed keywords

BUDESONIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE; SALBUTAMOL; VOLUMATIC;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEBULIZATION; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SYMPTOMATOLOGY;

EID: 23344448353     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1081/JAS-200062966     Document Type: Article

References (41)

1. Johnston SL, Pattermore PK, Sanderson G, et al. Community study of role of viral infections in exacerbation of asthma in 9-11 year old children. BMJ 1995; 310:1225-1229.
2. British Thoracic Society. Guidelines on the management of asthma. Thorax 1997; 52:S1-S21.
3. Global Strategy for Asthma Management and Prevention. National Institutes of Health. National Health, Lung and Blood Institute. Revised 2002.
4. Zora JA, Zimmerman D, Carey TL, O'Connell EJ, Yunginger JW. Hypotalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol 1986; 77:9-13.
5. Dolan LM, Keserwala HH, Holroyde JC, Fischer TJ. Short-term, high-dose, systemic steroids in children with asthma: the effect on the hypotalamic-pituitary-adrenal axis. J Allergy Clin Immunol 1987; 80:81-87.
6. Wolthers O, Pedersen S. Short-term linear growth in asthmatic children during treatment with prednisolone. BMJ 1990; 301:145-148.
7. Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma. A randomized controlled trial. Am J Respir Crit Care Med 2001; 163:32-36.
8. Tsai Y-G, Lee M-Y, Yang KD, et al. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J Pediatr 2001; 139:433-437.
9. Griffiths C. Steroids in exacerbations of asthma: tablets or inhalers? Thorax 1996; 51:1071-1072.
10. Hill JM. Nebulised corticosteroids in the treatment of asthma. Thorax 1999; 54:661-663.
11. Volovitz B, Soferman R, Blau H, Nussinovitch M, Varsano I. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes. J Allergy Clin Immunol 1998; 101:464-469.
12. Manjra AI, Price J, Lenney W, Hughes S, Barnacle H. Effect of nebulised fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir Med 2000; 94:1206-1214.
13. Edmonds ML, Camargo CA, Pollack CV, Rowe BH. The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. Ann Emerg Med 2002; 40:145-154.
14. Barnes N. Relative safety and efficacy of inhaled corticosteroids. J Allergy Clin Immunol 1998; 101:S460-S464.
15. O'Byrne PM, Pedersen S. Measuring efficacy and safety of different inhaled corticosteroid preparations. J Allergy Clin Immunol 1998; 102:879-886.
16. Barnes NC, Hallet C, Harris TA. Comparative efficacy and safety of fluticasone propionate at half microgram doses of budesonide and beclomethasone dipropionate in asthma: a meta analysis. Respir Med 1998; 92:95-104.
17. Ferguson AC, Spier S, Manjra A, Versteegh FGA, Mark S, Zhang P. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate to budesonide. J Pediatr 1999; 134:422-427.
18. Polgar G, Promadhat V. Pulmonary Function Testing in Children: Techniques and Standards. Philadelphia: WB Saunders Co., 1971.
19. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152:1107-1136.
20. Leflein J, Brown E, Hill M, et al. Delivery of glucocorticoids by jet nebulization. Aerosol characteristics and output. J Allergy Clin Immunol 1995; 95:944-949.
21. Westlake WJ. Bioequivalence testing-a need to rethink. Biometrics 1981; 37:591-593.
22. de Benedictis FM, Boner A, Cavagni G, Caffarelli C, Ferraro L, Cantini L. Treating asthma in children with beclomethasone dipropionate: Pulvinal vs. Diskhaler. J Aerosol Med 2000; 13:35-41.
23. Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child 1993; 68:85-87.
24. Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child 1990; 65:407-410.
25. Sverdymyr J, Nyberg E, Asbrink-Nilsson E, Hedlin G. Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections. Acta Paediatr 1995; 84:884-888.
26. Sano F, Cortez GK, Sole D, Naspitz CK. Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone. J Allergy Clin Immunol 2000; 105:699-703.
27. Devidayal Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr 1999; 88:835-840.
28. Volovitz B, Bentur L, Finkelstein Y, Mansour J, Shalitin S, Nussinovitch M. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol 1998; 102:605-609.
29. Johnson M. Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol 1998; 101:S434-S439.
30. Gern JE, Eggleston PA, Schubert KC, et al. Peak flow variation in childhood asthma: a three-year analysis. J Allergy Clin Immunol 1994; 93:706-716.
31. Brand PL, Duiverman EJ, Waalkens HJ, van Essen-Zandvliet EEM, Kerrebijn K, The Dutch CNSLD Study Group. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Thorax 1999; 54:103-107.
32. McIntyre HD, Mitchell CA, Bowler SD, Armstrong JA, Wooler JA, Cowley DM. Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens. Thorax 1995; 50:1280-1284.
33. Price J, Lenney W, Duncan C, et al. HPA-axis effects of nebulised fluticasone propionate compared with oral prednisolone in childhood asthma. Respir Med 2002; 96:625-631.
34. Hoekstra MO, Grol MH, Bouman K, et al. Fluticasone propionate in children with moderate asthma. Am J Respir Crit Care Med 1996; 154:1039-1044.
35. Lipworth BJ. Systematic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999; 159:941-955.
36. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 1995; 95:29-33.
37. Shapiro G, Bronsky EA, LaForce CF, et al. Dose-related efficacy of budesonide administered via a dry powder inhaled in the treatment of children with moderate to severe persistent asthma. J Pediatr 1998; 132:976-982.
38. Gershman NH, Wong HH, Liu JT, Fahy JV. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. Eur Respir J 2000; 15:11-18.
39. Schuh S, Reisman J, Alshehri M, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 2000; 343:689-694.
40. Doull IJM, Lampe FC, Smith S, Schreiber J, Freezer NJ, Holgate ST. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised, double-blind, placebo-controlled trial. BMJ 1997; 315:858-862.
41. de Benedictis FM, Selvaggio D. Use of inhaler devices in pediatric asthma. Pediatr Drugs 2003; 5:629-638.